Toll Free: 1800 103 1369 Email Us:customercare@canmoney.in

Markets

Market

Income Statement

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

AstraZeneca Pharma India Ltd.

GO
Market Cap. ( ₹ in Cr. ) 21522.50 P/BV 25.88 Book Value ( ₹ ) 332.64
52 Week High/Low ( ₹ ) 10691/7201 FV/ML 2/1 P/E(X) 185.96
Book Closure 18/07/2025 EPS ( ₹ ) 46.30 Div Yield (%) 0.37
(₹ in Crs.)

ParticularsMar 25Mar 24Mar 23
Months121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARAR
FaceValue2.002.002.00
    
    
INCOME   
Revenue From Operations [Net]1713.291295.531002.97
Other Operating Revenues3.000.000.00
Total Operating Revenues1716.291295.531002.97
    
Other Income40.6334.8026.10
Total Revenue1756.921330.331029.07
    
EXPENSES   
Cost Of Materials Consumed287.13129.0284.38
Purchase Of Stock-In Trade1008.82499.31324.46
Changes In Inventories Of FG,WIP And Stock-In Trade-332.94-33.77-48.86
Employee Benefit Expenses257.44241.45259.10
Finance Costs1.461.200.63
Depreciation And Amortisation Expenses39.9914.9416.26
Other Expenses241.87275.07218.77
Total Expenses1503.771127.22854.74
    
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax253.15203.11174.33
    
Exceptional Items-96.7916.43-40.23
Profit/Loss Before Tax156.36219.54134.10
    
Tax Expenses-Continued Operations   
Current Tax60.1053.5538.30
Deferred Tax-19.92-0.90-3.49
Tax For Earlier Years0.445.380.00
Total Tax Expenses40.6258.0334.81
Profit/Loss After Tax And Before ExtraOrdinary Items115.74161.5199.29
    
Profit/Loss From Continuing Operations115.74161.5199.29
    
Profit/Loss For The Period115.74161.5199.29
    
OTHER INFORMATION   
    
EARNINGS PER SHARE   
Basic EPS (Rs.)46.3064.6039.70
Diluted EPS (Rs.)46.3064.6039.70
    
DIVIDEND AND DIVIDEND PERCENTAGE   
Equity Share Dividend60.0040.0020.00
Equity Dividend Rate (%)1600.001200.00800.00
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.